Press Coverage

Subscribe to Our Blog. Stay up to date with the latest news and insights.

2 min read

A Practical Guide to Using Machine Learning for RBQM in a New Clinical Trial Landscape, Upcoming Webinar Hosted by Xtalks

MORRISVILLE – October 1, 2021 – Remarque Systems is hosting a free webinar on October 13. The featured speakers will discuss how to align your team on the basic RBQM framework to reorient your trial management strategy toward your goals and where in the RBQM process, ML can be leveraged most easily. Attendees will learn

2 min read

Remarque Systems Secures Industry’s First Patent For Trial-Audited, Real-Time, Risk-Based Quality Management Platform

Capturing Every Action Taken Entirely Within Its RBQM SystemProvides Permanent Audit Trail, Enabling Rapid Compliance MORRISVILLE, N.C., September 28, 2021 — As regulatory oversight increasingly focuses on risk-based monitoring (RBM) technology, clinical trial sponsors need a straightforward way to input and audit data in real time. Remarque Systems’ platform is the industry’s first patented trail-audited

3 min read

Remarque Systems Collaborates With Oracle For Integration of Risk Management System

MORRISVILLE, N.C., September 22, 2021 — Remarque Systems and Oracle Health Sciences have announced a collaboration to help customers manage clinical trial risk in real-time as part of the latest expansion of the Oracle Clinical One platform. Remarque Systems is a member of Oracle PartnerNetwork (OPN). Now customers can use a single unified platform that

3 min read

Remarque Systems Launches Application That Speeds Study Start-Up, and Enhances Team Collaboration and Sponsor Communications

Application Hastens Demise of Time-Consuming, Outdated Spreadsheets DURHAM, N.C., March 29, 2021 /PRNewswire/ — Industry-wide, spreadsheets have long been the go-to method for tracking clinical trial start-up, but now a new purpose-built solution is available that has been created expressly to improve efficiency and quality in a clinical trial’s study start-up across the entire clinical development process. Remarque